Verve Therapeutics
VERV
#6795
Rank
โ‚น41.34 B
Marketcap
โ‚น488.38
Share price
11.24%
Change (1 day)
-58.91%
Change (1 year)

Verve Therapeutics (VERV) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น45.93 Billion

According to Verve Therapeutics's latest financial reports the company has โ‚น45.93 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Verve Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น51.94 B13.14%
2022-12-31โ‚น45.91 B71.13%
2021-12-31โ‚น26.82 B408.7%
2020-12-31โ‚น5.27 B293.76%
2019-12-31โ‚น1.33 B